Literature DB >> 14623961

Mapping dominant-negative mutations of anthrax protective antigen by scanning mutagenesis.

Michael Mourez1, Ming Yan, D Borden Lacy, Lisa Dillon, Lori Bentsen, Amy Marpoe, Clémence Maurin, Eileen Hotze, Darran Wigelsworth, Ruth-Anne Pimental, Jimmy D Ballard, R John Collier, Rodney K Tweten.   

Abstract

The protective antigen (PA) moiety of anthrax toxin transports edema factor and lethal factor to the cytosol of mammalian cells by a mechanism that depends on its ability to oligomerize and form pores in the endosomal membrane. Previously, some mutated forms of PA, designated dominant negative (DN), were found to coassemble with wild-type PA and generate defective heptameric pore-precursors (prepores). Prepores containing DN-PA are impaired in pore formation and in translocating edema factor and lethal factor across the endosomal membrane. To create a more comprehensive map of sites within PA where a single amino acid replacement can give a DN phenotype, we used automated systems to generate a Cys-replacement mutation for each of the 568 residues of PA63, the active 63-kDa proteolytic fragment of PA. Thirty-three mutations that reduced PA's ability to mediate toxicity at least 100-fold were identified in all four domains of PA63. A majority (22) were in domain 2, the pore-forming domain. Seven of the domain-2 mutations, located in or adjacent to the 2beta6 strand, the 2beta7 strand, and the 2beta10-2beta11 loop, gave the DN phenotype. This study demonstrates the feasibility of high-throughput scanning mutagenesis of a moderate sized protein. The results show that DN mutations cluster in a single domain and implicate 2beta6 and 2beta7 strands and the 2beta10-2beta11 loop in the conformational rearrangement of the prepore to the pore. They also add to the repertoire of mutations available for structure-function studies and for designing new antitoxic agents for treatment of anthrax.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14623961      PMCID: PMC283502          DOI: 10.1073/pnas.2436299100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  Dominant-negative mutants of a toxin subunit: an approach to therapy of anthrax.

Authors:  B R Sellman; M Mourez; R J Collier
Journal:  Science       Date:  2001-04-27       Impact factor: 47.728

2.  Point mutations in anthrax protective antigen that block translocation.

Authors:  B R Sellman; S Nassi; R J Collier
Journal:  J Biol Chem       Date:  2000-12-11       Impact factor: 5.157

3.  Involvement of domain 3 in oligomerization by the protective antigen moiety of anthrax toxin.

Authors:  J Mogridge; M Mourez; R J Collier
Journal:  J Bacteriol       Date:  2001-03       Impact factor: 3.490

4.  Complete cysteine-scanning mutagenesis and site-directed chemical modification of the Tn10-encoded metal-tetracycline/H+ antiporter.

Authors:  N Tamura; S Konishi; S Iwaki; T Kimura-Someya; S Nada; A Yamaguchi
Journal:  J Biol Chem       Date:  2001-02-06       Impact factor: 5.157

5.  A dominant negative mutant of Bacillus anthracis protective antigen inhibits anthrax toxin action in vivo.

Authors:  Y Singh; H Khanna; A P Chopra; V Mehra
Journal:  J Biol Chem       Date:  2001-03-16       Impact factor: 5.157

6.  Arresting pore formation of a cholesterol-dependent cytolysin by disulfide trapping synchronizes the insertion of the transmembrane beta-sheet from a prepore intermediate.

Authors:  E M Hotze; E M Wilson-Kubalek; J Rossjohn; M W Parker; A E Johnson; R K Tweten
Journal:  J Biol Chem       Date:  2000-12-01       Impact factor: 5.157

Review 7.  Toxins of Bacillus anthracis.

Authors:  F Brossier; M Mock
Journal:  Toxicon       Date:  2001-11       Impact factor: 3.033

Review 8.  Anthrax.

Authors:  M Mock; A Fouet
Journal:  Annu Rev Microbiol       Date:  2001       Impact factor: 15.500

9.  Identification of the cellular receptor for anthrax toxin.

Authors:  K A Bradley; J Mogridge; M Mourez; R J Collier; J A Young
Journal:  Nature       Date:  2001-11-08       Impact factor: 49.962

10.  Functional analysis of the carboxy-terminal domain of Bacillus anthracis protective antigen.

Authors:  F Brossier; J C Sirard; C Guidi-Rontani; E Duflot; M Mock
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

View more
  36 in total

1.  Select human anthrax protective antigen epitope-specific antibodies provide protection from lethal toxin challenge.

Authors:  Sherry R Crowe; Linda L Ash; Renata J M Engler; Jimmy D Ballard; John B Harley; A Darise Farris; Judith A James
Journal:  J Infect Dis       Date:  2010-07-15       Impact factor: 5.226

2.  Structure of heptameric protective antigen bound to an anthrax toxin receptor: a role for receptor in pH-dependent pore formation.

Authors:  D Borden Lacy; Darran J Wigelsworth; Roman A Melnyk; Stephen C Harrison; R John Collier
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-23       Impact factor: 11.205

Review 3.  Ratcheting up protein translocation with anthrax toxin.

Authors:  Geoffrey K Feld; Michael J Brown; Bryan A Krantz
Journal:  Protein Sci       Date:  2012-03-30       Impact factor: 6.725

4.  Identification of functional domains of Clostridium septicum alpha toxin.

Authors:  Jody A Melton-Witt; Lori M Bentsen; Rodney K Tweten
Journal:  Biochemistry       Date:  2006-12-05       Impact factor: 3.162

5.  Membrane insertion by anthrax protective antigen in cultured cells.

Authors:  Maen Qa'dan; Kenneth A Christensen; Lei Zhang; Thomas M Roberts; R John Collier
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

6.  Assembly and disassembly kinetics of anthrax toxin complexes.

Authors:  Kenneth A Christensen; Bryan A Krantz; R John Collier
Journal:  Biochemistry       Date:  2006-02-21       Impact factor: 3.162

7.  Mapping of a domain required for protein-protein interactions and inhibitory activity of a Helicobacter pylori dominant-negative VacA mutant protein.

Authors:  Victor J Torres; Mark S McClain; Timothy L Cover
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

8.  Phenylalanine-427 of anthrax protective antigen functions in both pore formation and protein translocation.

Authors:  Jianjun Sun; Alexander E Lang; Klaus Aktories; R John Collier
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-11       Impact factor: 11.205

9.  Selection and evaluation of the immunogenicity of protective antigen mutants as anthrax vaccine candidates.

Authors:  Ming Yan; Michael H Roehrl; Emre Basar; Julia Y Wang
Journal:  Vaccine       Date:  2007-12-26       Impact factor: 3.641

10.  Efficient neutralization of antibody-resistant forms of anthrax toxin by a soluble receptor decoy inhibitor.

Authors:  Shilpi Sharma; Diane Thomas; John Marlett; Marianne Manchester; John A T Young
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.